Acute-phase proteins in osteoarthritis (Q40956233)

25 September 2017

1 reference

title

Acute-phase proteins in osteoarthritis (English)

1 reference

25 September 2017

1 reference

Sipe JD

1

1 reference

25 September 2017

1 October 1995

1 reference

Seminars in Arthritis and Rheumatism

25 September 2017

1 reference

25 September 2017

25

1 reference

25 September 2017

2

1 reference

25 September 2017

75-86

1 reference

The biology of osteoarthritis

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Collagenase and collagenolytic activity in human osteoarthritic cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Pathogenesis of osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Cytokine reduction in the treatment of joint conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

The Synovial Microvascular Derangement in Rheumatoid Arthritis and Osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

The value of C-reactive protein measurement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Structural and functional studies on the human hepatic interleukin-6 receptor. Molecular cloning and overexpression in HepG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Proteinase-mediated cartilage degradation in osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Proteoglycan-degrading acid metalloprotease activity in human osteoarthritic cartilage, and the effect of intraarticular steroid injections

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Neutral proteases in human osteoarthritic synovium

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Cathepsin B and cysteine protease inhibitors in human osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Identification of catabolin, a protein fro synovium which induces degradation of cartilage in organ culture

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Isolation of an interleukin-1-like factor from human joint effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Type IX collagen is a potent inducer of PGE2 and interleukin 1 production by human monocyte macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Stimulation of procollagenase synthesis in human rheumatoid synovial fibroblasts by mononuclear cell factor/interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Interleukin-1-induced interleukin-6 is required for the inhibition of proteoglycan synthesis by interleukin-1 in human articular cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Interleukin-1 beta induces synthesis and secretion of interleukin-6 in human chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Chondrocyte-mediated depletion of articular cartilage proteoglycans in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Regulation of human normal and osteoarthritic chondrocyte interleukin-1 receptor by antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

The erythrocyte sedimentation rate. Guidelines for rational use.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Serum C-reactive protein levels in disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

C-reactive protein fifty years on

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Reduction of acute-phase proteins with tenidap sodium, a cytokine-modulating anti-rheumatic drug

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Serum amyloid A protein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Changes in Human Serum Amyloid A and C-Reactive Protein after Etiocholanolone-Induced Inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Response of the acute-phase reactants, C-reactive protein and serum amyloid A protein, to antibiotic treatment of Whipple's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

C-reactive protein in rheumatology

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Direct binding enzyme-linked immunosorbent assay (ELISA) for serum amyloid A (SAA).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Autocrine induction of collagenase by serum amyloid A-like and beta 2-microglobulin-like proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

What are the 'best' measurements for monitoring patients during short-term second-line therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Articular indices of joint inflammation in rheumatoid arthritis. Correlation with the acute-phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

A monoclonal antibody sandwich immunoassay for serum amyloid A (SAA) protein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Relationships between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Affinity electrophoresis for diagnosis of cancer and inflammatory conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Granulocyte elastase as a new biochemical marker in the diagnosis of chronic joint diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Release of cartilage macromolecules into the synovial fluid in patients with acute and prolonged phases of reactive arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

Measurement of urinary desmosine by isotope dilution and high performance liquid chromatography. Correlation between elastase-induced air-space enlargement in the hamster and elevation of urinary desmosine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980020-4

7 January 2021

10.1016/S0049-0172(95)80020-4

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

8578314